Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03533946 · ClinicalTrials.gov registry record · Phase 2
Rucaparib in Nonmetastatic prOstAte With BRCAness
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT03533946 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 7 participants.
The verdict
NCT03533946, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a single arm, open label, phase II trial to assess efficacy of rucaparib.
Interventions
- DRUG Rucaparib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2023-01-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03533946
The ClinicalTrials.gov registry entry for NCT03533946 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rucaparib is the first listed.
NCT03533946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03533946 about?
NCT03533946 is a clinical study titled "Rucaparib in Nonmetastatic prOstAte With BRCAness". This is a single arm, open label, phase II trial to assess efficacy of rucaparib.
What is the current status of trial NCT03533946?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2019-05-20. Estimated completion is 2023-01-12.
What interventions are being tested in trial NCT03533946?
The interventions under investigation include: Rucaparib (DRUG).
Who is sponsoring clinical trial NCT03533946?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.